Literature DB >> 12172351

Serotonin syndrome as a result of fluoxetine in a patient with tramadol abuse: plasma level-correlated symptomatology.

Christian Lange-Asschenfeldt, Harald Weigmann, Christoph Hiemke, Klaus Mann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12172351     DOI： 10.1097/00004714-200208000-00022

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  6 in total

Review 1.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  Serotonin syndrome.

Authors:  Jacqueline Volpi-Abadie; Adam M Kaye; Alan David Kaye
Journal:  Ochsner J       Date:  2013

Review 3.  Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol.

Authors:  David H Epstein; Kenzie L Preston; Donald R Jasinski
Journal:  Biol Psychol       Date:  2006-02-23       Impact factor: 3.251

4.  Tramadol: seizures, serotonin syndrome, and coadministered antidepressants.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2009-04

5.  Interaction between tramadol and selective serotonin reuptake inhibitors: are doctors aware of potential risks in their prescription practice?

Authors:  Petra E Spies; J L W Hans Pot; Roel P J Willems; Jacqueline M Bos; Cornelis Kramers
Journal:  Eur J Hosp Pharm       Date:  2016-03-23

Review 6.  Tramadol Extended-Release for the Management of Pain due to Osteoarthritis.

Authors:  Chiara Angeletti; Cristiana Guetti; Antonella Paladini; Giustino Varrassi
Journal:  ISRN Pain       Date:  2013-09-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.